Thymic stromal lymphopoietin receptor molecules and uses thereof

Details for Australian Patent Application No. 2001270266 (hide)

Owner Amgen Inc.

Inventors Chang, Ming-Shi; Saris, Christiaan M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001270266

PCT Pub. Number WO02/00724

Priority 60214866 28.06.00 US

Filing date 28 June 2001

Wipo publication date 8 January 2002

Acceptance publication date 21 October 2004

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

Event Publications

21 October 2004 Application Accepted

  Published as AU-B-2001270266

17 February 2005 Standard Patent Sealed

8 September 2005 Section 223 Application Received

  Amgen Inc. An application to extend the time from 28 May 2004 to 28 Aug 2005 in which to file search results has been filed . Address for service in Australia - Phillips Ormonde & Fitzpatrick 367 Collins Street Melbourne VIC 3000

27 October 2005 Section 223 Application Allowed

  Amgen Inc. The time in which to file search results has been extended to 28 Aug 2005. Address for service in Australia - Phillips Ormonde & Fitzpatrick 367 Collins Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001270267

2001270265